Quarterly report pursuant to Section 13 or 15(d)

Common Stock

v3.22.2.2
Common Stock
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Common Stock

5. Common Stock

 

The Company has 150,000,000 shares of common stock, $0.001 par value per share, authorized as of June 30, 2022 and December 31, 2021, respectively. The Company had 97,469,000 and 97,469,000 shares issued and outstanding as of June 30, 2022 and December 31, 2021.

 

On August 6, 2021, the Company filed with the Delaware Secretary of State a Certificate of Amendment to the Certificate of Incorporation pursuant to which the number of shares of common stock the Company is authorized to issue was increased from 100,000,000 shares to 150,000,000 shares. The Certificate of Amendment was effective upon filing.

 

The holders of common stock are entitled to one vote for each share of common stock held.

 

The Company is party to the At-The-Market Offering Agreement, dated July 1, 2020 (“ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which the Company may issue and sell over time and from time to time, to or through Wainwright, up to $10,000,000 of shares of the Company’s common stock. During January 2021, the Company sold 1,030,000 shares of its common stock pursuant to the ATM Agreement for net proceeds of approximately $2,072,000. There were no sales under the ATM Agreement during the six months ended June 30, 2022.

 

On May 4, 2021, the Company entered into an underwriting agreement with H.C. Wainwright & Co., LLC, pursuant to which the Company agreed to issue and sell 26,000,000 shares of the Company’s common stock at a public offering price of $1.54 per share, less underwriting discounts and commissions (the “Offering”). The Company received approximately $36.4 million in net proceeds from the Offering, after deducting underwriting discounts and estimated offering expenses. The Offering closed on May 7, 2021.